Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland
NCT ID: NCT00473993
Last Updated: 2009-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
OBSERVATIONAL
2007-07-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our crossectional study investigates how many patients undergoing OMT are adequately investigated concerning hepatitis C. If not, why are they not adequately investigated and treated? Representative data are collected in the local clinics and medical practices involved in OMT in the Kanton of Zurich. The patients files are revised and the involved doctors are asked through a structured interview.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy
NCT01045278
Improving Hepatitis C Treatment in Injection Drug Users
NCT00148031
Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients
NCT02395198
Directly Observed Hepatitis C Treatment in Methadone Clinics
NCT01442311
Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment
NCT00844272
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Seidenberg, Arztpraxis A., M.D.
INDIV
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
André Seidenberg, Dr.med.
Role: STUDY_DIRECTOR
research fellow EHAM, University of Zurich
Related Links
Access external resources that provide additional context or updates about the study.
download of the protocol of the HepCOP-study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HepCOP Zurich
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.